parkinson disease (pd)
Showing 1 - 5 of 5
Mild Cognitive Impairment (MCI), Parkinson Disease (PD) Trial (CST-2032, matching for CST-2032, CST-107)
Withdrawn
- Mild Cognitive Impairment (MCI)
- Parkinson Disease (PD)
- CST-2032, matching placebo for CST-2032, CST-107
- (no location specified)
Oct 22, 2021
Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Completed
- Parkinson Disease (PD)
-
Calgary, Alberta, Canada
- +12 more
Jun 23, 2021
Parkinson Disease (PD), Chronic Heart Failure (CHF), COPD (COPD) Trial in Milano (SIDERA^B, Usual Care Program)
Unknown status
- Parkinson Disease (PD)
- +2 more
- SIDERA^B
- Usual Care Program
-
Milano, ItalyFondazione Don Carlo Gnocchi ONLUS
Jun 16, 2020
Parkinson Disease (PD), Paralysis; Supranuclear Trial in Cassino (3D gait analysis, rsfMRI, Montreal Cognitive assesment (MoCA))
Completed
- Parkinson Disease (PD)
- Paralysis; Supranuclear
- 3D gait analysis
- +2 more
-
Cassino, Frosinone, ItalyCasa di cura San Raffaele Cassino
May 6, 2020
Parkinson Disease (PD) Trial in Gainesville (Doorway Width Test, Door Frame Color Test)
Completed
- Parkinson Disease (PD)
- Doorway Width Test
- Door Frame Color Test
-
Gainesville, FloridaShimberg Center for Housing Studies
Jan 2, 2020